Literature DB >> 1532536

A population of early fetal thymocytes expressing Fc gamma RII/III contains precursors of T lymphocytes and natural killer cells.

H R Rodewald1, P Moingeon, J L Lucich, C Dosiou, P Lopez, E L Reinherz.   

Abstract

We have identified a dominant fetal thymocyte population at day 14.5 of gestation in the mouse that lacks CD4 and CD8 but expresses Fc gamma RII/III several days prior to acquisition of the T cell receptor (TCR) in vivo. If maintained in a thymic microenvironment, this population of CD4-CD8-TCR-Fc gamma RII/III+ thymocytes differentiates first into CD4+CD8+TCRlowFc gamma RII/III- thymocytes and subsequently CD4+CD8-TCRhighFc gamma RII/III- and CD4-CD8+TCRhighFc gamma RII/III- mature Ti alpha-beta lineage T cells. However, if removed from the thymus, the CD4-CD8-TCR-Fc gamma RII/III+ thymocyte population selectively generates functional natural killer (NK) cells in vivo as well as in vitro. These findings show that a cellular pool of Fc gamma RII/III+ precursors gives rise to T and NK lineages in a microenvironment-dependent manner. Moreover, they suggest a hitherto unrecognized role for Fc receptors on primitive T cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532536     DOI: 10.1016/0092-8674(92)90125-v

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  60 in total

1.  Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow.

Authors:  S Dejbakhsh-Jones; S Strober
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Clonable progenitors committed to the T lymphocyte lineage in the mouse bone marrow; use of an extrathymic pathway.

Authors:  S Dejbakhsh-Jones; M E Garcia-Ojeda; D Chatterjea-Matthes; D Zeng; S Strober
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 3.  Progression of regulatory gene expression states in fetal and adult pro-T-cell development.

Authors:  Elizabeth-Sharon David-Fung; Mary A Yui; Marissa Morales; Hua Wang; Tom Taghon; Rochelle A Diamond; Ellen V Rothenberg
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

Review 4.  Stromal-cell regulation of natural killer cell differentiation.

Authors:  Claude Roth; Carla Rothlin; Sylvain Riou; David H Raulet; Greg Lemke
Journal:  J Mol Med (Berl)       Date:  2007-04-11       Impact factor: 4.599

Review 5.  Extrinsic and intrinsic regulation of early natural killer cell development.

Authors:  Markus D Boos; Kevin Ramirez; Barbara L Kee
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  Core binding factors are necessary for natural killer cell development and cooperate with Notch signaling during T-cell specification.

Authors:  Yalin Guo; Ivan Maillard; Sankhamala Chakraborti; Ellen V Rothenberg; Nancy A Speck
Journal:  Blood       Date:  2008-04-04       Impact factor: 22.113

7.  Identification of tissue-infiltrating lymphocytes expressing PEN5, a mucin-like glycoprotein selectively expressed on natural killer cells.

Authors:  E Vivier; M Munroe; P Ariniello; P Anderson
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

8.  Development of thymic NK cells from double negative 1 thymocyte precursors.

Authors:  Claudia L Vargas; Jennifer Poursine-Laurent; Liping Yang; Wayne M Yokoyama
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

9.  KMT1E-mediated chromatin modifications at the FcγRIIb promoter regulate thymocyte development.

Authors:  F J Martin; Y Xu; F Lohmann; D N Ciccone; T B Nicholson; J J Loureiro; T Chen; Q Huang
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

10.  Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells.

Authors:  M Taniguchi; H Koseki; T Tokuhisa; K Masuda; H Sato; E Kondo; T Kawano; J Cui; A Perkes; S Koyasu; Y Makino
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.